Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AGN - Why AbbVie Might Fall After The Mega-Merger With Allergan


AGN - Why AbbVie Might Fall After The Mega-Merger With Allergan

Markets are bipolar in their sentiment on AbbVie (ABBV). When it first announced the buyout of Allergan (AGN) in June, the stock began a four-month-long descent. By September, sentiment changed. Drug stocks staged a broad rally, taking AbbVie stock with it. Strong Q4 results, a dividend hike, and healthy demand for its $30 billion bond offering sent ABBV stock to $90. Yet, as the merger looms, AbbVie may underperform in the short term.

Allergan Acquisition Generates Significant Value

Generic competition for AbbVie's Humira forces the company to find other ways to

Read more ...

Stock Information

Company Name: Allergan plc
Stock Symbol: AGN
Market: NYSE
Website: allergan.com

Menu

AGN AGN Quote AGN Short AGN News AGN Articles AGN Message Board
Get AGN Alerts

News, Short Squeeze, Breakout and More Instantly...